210 related articles for article (PubMed ID: 29735912)
1. Towards Resolving the Pro- and Anti-Tumor Effects of the Aryl Hydrocarbon Receptor.
Narasimhan S; Stanford Zulick E; Novikov O; Parks AJ; Schlezinger JJ; Wang Z; Laroche F; Feng H; Mulas F; Monti S; Sherr DH
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29735912
[TBL] [Abstract][Full Text] [Related]
2. Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation.
Hall JM; Barhoover MA; Kazmin D; McDonnell DP; Greenlee WF; Thomas RS
Mol Endocrinol; 2010 Feb; 24(2):359-69. PubMed ID: 20032195
[TBL] [Abstract][Full Text] [Related]
3. The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells.
Stanford EA; Wang Z; Novikov O; Mulas F; Landesman-Bollag E; Monti S; Smith BW; Seldin DC; Murphy GJ; Sherr DH
BMC Biol; 2016 Mar; 14():20. PubMed ID: 26984638
[TBL] [Abstract][Full Text] [Related]
4. Aryl hydrocarbon receptor: An emerging player in breast cancer pathogenesis and its potential as a drug target (Review).
Chen C; Wang Z; Liao Z; Zhang Y; Lei W; Shui X
Mol Med Rep; 2024 Jan; 29(1):. PubMed ID: 37997818
[TBL] [Abstract][Full Text] [Related]
5. 1'H-Indole-3'-Carbonyl-Thiazole-4-Carboxylic Acid Methyl Ester Blocked Human Glioma Cell Invasion via Aryl Hydrocarbon Receptor's Regulation of Cytoskeletal Contraction.
Zhao L; Shu Q; Sun H; Ma Y; Kang D; Zhao Y; Lu J; Gong P; Yang F; Wan F
Biomed Res Int; 2020; 2020():2616930. PubMed ID: 33083460
[TBL] [Abstract][Full Text] [Related]
6. Aryl hydrocarbon receptor ligands in cancer: friend and foe.
Murray IA; Patterson AD; Perdew GH
Nat Rev Cancer; 2014 Dec; 14(12):801-14. PubMed ID: 25568920
[TBL] [Abstract][Full Text] [Related]
7. Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target.
Safe S; Lee SO; Jin UH
Toxicol Sci; 2013 Sep; 135(1):1-16. PubMed ID: 23771949
[TBL] [Abstract][Full Text] [Related]
8. The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers.
Zudaire E; Cuesta N; Murty V; Woodson K; Adams L; Gonzalez N; Martínez A; Narayan G; Kirsch I; Franklin W; Hirsch F; Birrer M; Cuttitta F
J Clin Invest; 2008 Feb; 118(2):640-50. PubMed ID: 18172554
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the aryl hydrocarbon receptor/polyamine biosynthesis axis suppresses multiple myeloma.
Bianchi-Smiraglia A; Bagati A; Fink EE; Affronti HC; Lipchick BC; Moparthy S; Long MD; Rosario SR; Lightman SM; Moparthy K; Wolff DW; Yun DH; Han Z; Polechetti A; Roll MV; Gitlin II; Leonova KI; Rowsam AM; Kandel ES; Gudkov AV; Bergsagel PL; Lee KP; Smiraglia DJ; Nikiforov MA
J Clin Invest; 2018 Oct; 128(10):4682-4696. PubMed ID: 30198908
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of breast cancer progression induced by environment-polluting aryl hydrocarbon receptor agonists.
Miret NV; Pontillo CA; Buján S; Chiappini FA; Randi AS
Biochem Pharmacol; 2023 Oct; 216():115773. PubMed ID: 37659737
[TBL] [Abstract][Full Text] [Related]
11. Omeprazole Inhibits Glioblastoma Cell Invasion and Tumor Growth.
Jin UH; Michelhaugh SK; Polin LA; Shrestha R; Mittal S; Safe S
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32731514
[No Abstract] [Full Text] [Related]
12. The combination of IDO and AHR blockers reduces the migration and clonogenicity of breast cancer cells.
Soltani-Asl M; Azimnasab-Sorkhabi P; Yoshinaga TT; de Oliveira Massoco C; Kfoury JR
Immunol Res; 2023 Dec; ():. PubMed ID: 38153625
[TBL] [Abstract][Full Text] [Related]
13. A potential role for AHR in SARS-CoV-2 pathology.
Giovannoni F; Li Z; Garcia CC; Quintana FJ
Res Sq; 2020 Apr; ():. PubMed ID: 32702728
[TBL] [Abstract][Full Text] [Related]
14. Zebrafishing for toxins.
Bordon Y
Nat Rev Immunol; 2022 Dec; 22(12):718. PubMed ID: 36357705
[No Abstract] [Full Text] [Related]
15. In vitro toxicity and in silico docking analysis of two novel selective AH-receptor modulators.
Mahiout S; Tagliabue SG; Nasri A; Omoruyi IM; Pettersson L; Bonati L; Pohjanvirta R
Toxicol In Vitro; 2018 Oct; 52():178-188. PubMed ID: 29908305
[TBL] [Abstract][Full Text] [Related]
16. Aryl hydrocarbon receptor (AhR) a possible target for the treatment of skin disease.
Napolitano M; Patruno C
Med Hypotheses; 2018 Jul; 116():96-100. PubMed ID: 29857917
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Activation of
Donovan MG; Selmin OI; Doetschman TC; Romagnolo DF
Nutrients; 2019 Oct; 11(11):. PubMed ID: 31652854
[TBL] [Abstract][Full Text] [Related]
18. AhR and Cancer: From Gene Profiling to Targeted Therapy.
Paris A; Tardif N; Galibert MD; Corre S
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451095
[TBL] [Abstract][Full Text] [Related]
19. How the AHR Became Important in Cancer: The Role of Chronically Active AHR in Cancer Aggression.
Wang Z; Snyder M; Kenison JE; Yang K; Lara B; Lydell E; Bennani K; Novikov O; Federico A; Monti S; Sherr DH
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396563
[TBL] [Abstract][Full Text] [Related]
20. Possible Strategies to Reduce the Tumorigenic Risk of Reprogrammed Normal and Cancer Cells.
Lin YC; Ku CC; Wuputra K; Liu CJ; Wu DC; Satou M; Mitsui Y; Saito S; Yokoyama KK
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
